These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9917245)

  • 21. Psoriasis may not be an independent predictor for the use of cardiovascular and anti-diabetic drugs: a 5-year prevalence study.
    Wakkee M; Meijer W; Neumann HA; Herings RM; Nijsten T
    Acta Derm Venereol; 2009; 89(5):476-83. PubMed ID: 19734972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes management: More than just cardiovascular risk?
    Zimmerman RS; Pantalone KM
    Cleve Clin J Med; 2014 Nov; 81(11):672-6. PubMed ID: 25368217
    [No Abstract]   [Full Text] [Related]  

  • 23. Increasing attention.
    NicNiocaill B; Williams SD; Gölitz P
    ChemMedChem; 2008 Jan; 3(1):3-5. PubMed ID: 18172911
    [No Abstract]   [Full Text] [Related]  

  • 24. Guidelines for the use of oral hypoglycemic drug therapy: the balance of risks versus benefits.
    Poffenbarger PL; White FA
    Conn Med; 1975 Mar; 39(3):137-43. PubMed ID: 804378
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypoglycemic treatment. Guidelines for the non-insulin-dependent diabetic. Council on Scientific Affairs.
    JAMA; 1980 May 23-30; 243(20):2078-9. PubMed ID: 6990029
    [No Abstract]   [Full Text] [Related]  

  • 26. FDA upholds findings of UGDP study.
    JAMA; 1979 Jan; 241(1):17-8. PubMed ID: 758481
    [No Abstract]   [Full Text] [Related]  

  • 27. [The trend of new drug development for the treatment of diabetes mellitus].
    Kaku K
    Nihon Rinsho; 2015 Dec; 73(12):2108-14. PubMed ID: 26666161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular safety trials: be careful what you wish for.
    Bloomgarden Z; Grunberger G
    J Diabetes; 2014 Jan; 6(1):1-3. PubMed ID: 24103189
    [No Abstract]   [Full Text] [Related]  

  • 29. Future therapy of diabetes mellitus.
    Takei I; Kasatani T
    Biomed Pharmacother; 2004 Dec; 58(10):578-81. PubMed ID: 15589066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The sugargate coverup.
    Biron P
    Can Med Assoc J; 1975 Aug; 113(3):179, 181. PubMed ID: 1139511
    [No Abstract]   [Full Text] [Related]  

  • 31. Dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes: decongesting the matter.
    Vaduganathan M; Bhatt DL
    Eur Heart J; 2015 Jun; 36(24):1497-8. PubMed ID: 26295082
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current therapeutic trends in clinical medicine. I].
    Van Cauwenberge H; Luyckx A
    Rev Med Liege; 1974 Sep; 29(18):525-38. PubMed ID: 4155112
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral hypoglycemic agents.
    Breidahl HD
    Med J Aust; 1973 Apr; 1(16):815-6. PubMed ID: 4707804
    [No Abstract]   [Full Text] [Related]  

  • 34. Diabetes update with a cardiac perspective.
    Dyck B
    Prog Cardiovasc Nurs; 1998; 13(2):28-31, 36. PubMed ID: 9802114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The oral hypoglycemic controversy. Stay as sweet as you are.
    Gregory DR
    Leg Aspects Med Pract; 1979 Mar; 7(3):16-9. PubMed ID: 106193
    [No Abstract]   [Full Text] [Related]  

  • 36. The oral antidiabetic drugs: pro and con.
    Fletcher HP
    Am J Nurs; 1976 Apr; 76(4):596-9. PubMed ID: 1046887
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of 16-week monotherapy with acarbose on cardiovascular risk factors in obese subjects with non-insulin-dependent diabetes mellitus: a controlled, double-blind comparison study with placebo.
    Calle-Pascual A; Garcia-Honduvilla J; Martin-Alvarez PJ; Calle JR; Maranes JP
    Diabetes Metab; 1996 Jun; 22(3):201-2. PubMed ID: 8697309
    [No Abstract]   [Full Text] [Related]  

  • 38. Diabetes mellitus and insulin therapy in infective endocarditis.
    Wang A
    Eur Heart J; 2007 Jan; 28(1):3-4. PubMed ID: 17098756
    [No Abstract]   [Full Text] [Related]  

  • 39. Could clinical inertia in part explain the unexpected association of insulin therapy with poorer cardiovascular outcomes in observational studies on diabetes?
    Giorda CB
    Diabetes Res Clin Pract; 2011 Jun; 92(3):e47-8. PubMed ID: 21035888
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral hypoglycemic agents. To use or not use that is the question.
    Dippe SE
    Ariz Med; 1979 Jun; 36(6):437-8. PubMed ID: 454215
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.